Puracap Pharmaceutical LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Puracap Pharmaceutical LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10654
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Puracap Pharmaceutical LLC (PuraCap) is a drug development company that offers prescription generics and OTC products. The company provides over the counter soft gels and oral solid dosage healthcare products for upper respiratory, pain relief, cough and cold, sleep aid, gastrointestinal, analgesics, antihistamine, digestive solutions and allergy. It uses soft gelatin capsule technology for the development of new medications. PuraCap offers contract manufacturing and business development services. The company sells its products through a network of distributors, mass merchandisers, food and grocery retailers, and drug store chains. It operates through its facilities located in the US and China. PuraCap is headquartered in Piscataway, New Jersey, the US.

Puracap Pharmaceutical LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Puracap Pharma and Dangdai International Enter into Joint Venture Agreement 10
Acquisition 11
Humanwell Healthcare and PuraCap Pharma Acquire 100% Stake in Epic Pharma 11
Puracap Pharma Acquires Blu Pharma and Blu Caribe 13
Puracap Pharmaceutical LLC – Key Competitors 14
Puracap Pharmaceutical LLC – Key Employees 15
Puracap Pharmaceutical LLC – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Key Facts 2
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Puracap Pharmaceutical LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Puracap Pharma and Dangdai International Enter into Joint Venture Agreement 10
Humanwell Healthcare and PuraCap Pharma Acquire 100% Stake in Epic Pharma 11
Puracap Pharma Acquires Blu Pharma and Blu Caribe 13
Puracap Pharmaceutical LLC, Key Competitors 14
Puracap Pharmaceutical LLC, Key Employees 15
Puracap Pharmaceutical LLC, Subsidiaries 16
Puracap Pharmaceutical LLC, Joint Venture 17

List of Figures
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Puracap Pharmaceutical LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Puracap Pharmaceutical LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Walsh Group:企業の戦略的SWOT分析
    The Walsh Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Volkswind GmbH:企業の戦略的SWOT分析
    Volkswind GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Stockland Corp Ltd:企業の戦略・SWOT・財務分析
    Stockland Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Stockland Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sensus USA Inc:企業の戦略的SWOT分析
    Sensus USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Brookdale Senior Living Inc (BKD):製薬・医療:M&Aディール及び事業提携情報
    Summary Brookdale Senior Living Inc (Brookdale) operates senior living communities which provide properties with high quality service, care and living accommodations for residents. The company focuses on providing an independent living, assisted living, dementia care, skilled nursing, continuing car …
  • Promentis Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Promentis Pharmaceuticals Inc (Promentis Pharmaceuticals) is a biopharmaceutical company that discovers and develops drugs for the treatment of schizophrenia and other central nervous system disorders. The company also develops therapies for neuropsychiatric disorders. It offers metabotropic …
  • Aaron’s Inc:戦略・SWOT・企業財務分析
    Aaron's Inc - Strategy, SWOT and Corporate Finance Report Summary Aaron's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Schott AG:企業の戦略的SWOT分析
    Schott AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Allied Healthcare Products Inc (AHPI):企業の財務・戦略的SWOT分析
    Allied Healthcare Products Inc (AHPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Max Delbruck Center for Molecular Medicine:製薬・医療:M&Aディール及び事業提携情報
    Summary Max Delbruck Center for Molecular Medicine (MDC) is a biomedical research center that offers translating discoveries from molecular research into applications. The company’s research area services offer for cancer research, cardiovascular and metabolic disease, diseases of the nervous system …
  • Avior Integrated Products Inc.:企業の戦略・SWOT・財務情報
    Avior Integrated Products Inc. - Strategy, SWOT and Corporate Finance Report Summary Avior Integrated Products Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Rosneft Oil Co (ROSN)-エネルギー分野:企業M&A・提携分析
    Summary Rosneft Oil Company (Rosneft) is a vertically integrated oil and gas company that explores for, develops and produces crude oil, natural gas and condensates; and refines, markets and distributes petroleum products and petrochemicals. It has exploration assets across Western Siberia, Eastern …
  • Mitsubishi Heavy Industries Ltd (7011):企業の財務・戦略的SWOT分析
    Mitsubishi Heavy Industries Ltd (7011) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Capstone Therapeutics Corp (CAPS):企業の財務・戦略的SWOT分析
    Summary Capstone Therapeutics Corp (Capstone), formerly OrthoLogic Corp, is a biotechnology company that develops and sells novel peptides and other molecules for helping patients with under-served medical conditions. The company develops Apo E mimetic peptide molecule AEM-28 and its analogs that ha …
  • Martinrea International Inc:企業の戦略・SWOT・財務情報
    Martinrea International Inc - Strategy, SWOT and Corporate Finance Report Summary Martinrea International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Marui Group Co., Ltd.:企業の戦略・SWOT・財務情報
    Marui Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Marui Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • New Zealand Post Ltd:企業の戦略的SWOT分析
    New Zealand Post Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Tokio Marine Asia Pte. Ltd.
    Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Nano Intelligent Biomedical Engineering Corp (138610):医療機器:M&Aディール及び事業提携情報
    Summary Nano Intelligent Biomedical Engineering Corp (NIBEC) is a venture firm. The firm manufacture of tissue regeneration devices. It aims to research ideas for tissue regeneration treatments and to develop and manufacture devices for practical use. NIBEC offers bio fusion peptide-based products, …
  • Camargo Correa Sa:企業の戦略・SWOT・財務分析
    Camargo Correa Sa - Strategy, SWOT and Corporate Finance Report Summary Camargo Correa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆